MIS-C is an uncommon but devastating ill�ness that occurs mainly in children after exposure to SARS�COV-2 [1]. Early diagnosis, rapid treatment with supportive care, anti-inflammatory medications, and/or immunosup�pressants & immunomodulators with a multidisciplinary approach is essential for effective management of this con�dition. However, the optimal therapeutic strategy remains
obscure
Is data on this page outdated, violates copyrights or anything else? Report the problem now and we will take corresponding actions after reviewing your request.